Get started
Author

Kübra Oral

Observed names: Kubra Oral, Kübra ORAL, ORAL, KÜBRA, Oral, Kübra
Institution: Fırat University
ORCID: 0000-0001-6461-5811
Observed ORCID: 0000-0001-6461-5811
OpenAlex ID: A5071237459
Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity
2025 · Belgin Sever, Cüneyt Türkeş, et al. · Pharmaceuticals · 7
PDF
An Investigation of Saliva and Plasma Levels of Urotensin-2 in Recently Diagnosed Type 2 Diabetes Mellitus Patients on Metformin Treatment
2020 · NEVZAT GOZEL, Kubra Oral, et al. · Endokrynologia Polska · 6
Correlation of Triethylamine N-oxide (TMAO), LPS, and TNF-Alpha Levels With Clinical Features of the Disease in Patients With and Without Septic Shock Infected With COVID-19 Virus
2024 · Kübra Polat, Mehtap Gömleksiz, et al. · Clinical Therapeutics · 5
The Prognostic Significance of the Systemic Inflammation Response Index (SIRI) and HALP Score in Hodgkin’s Lymphoma
2026 · Kübra Oral, Ayşe Uysal · Diagnostics · 2
PDF
A case of Sheehan Syndrome with chronic diffuse muscle pain and weakness
2019 · Erhan Önalan, Şüheda Ataş, et al. · Medical Science and Discovery · 1
PDF
Real-World Effectiveness and Safety of Fixed-Duration Frontline Venetoclax–Obinutuzumab for Chronic Lymphocytic Leukemia: A Nationwide Multicenter Retrospective Cohort Study
2026 · Zeynep Tuğba Karabulut, Tuba Hacıbekiroğlu, et al. · Leukemia Research
Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study
2026 · Ufuk Demirci, Mehmet Baysal, et al. · Journal of Thrombosis and Thrombolysis
Evaluation of venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia: a real-life, single-center experience
2026 · Kübra Oral, Ayşe Uysal · BMC Cancer
PEGylated Interferon-α Treatment in Polycythemia Vera and Essential Thrombocythemia: A Single Center, Real-Life Experience
2026 · Ayse Uysal, Mustafa Merter, et al. · Indian Journal of Hematology and Blood Transfusion
Assessment of Clinical Course and Treatment Responses in Our Patients with Immune Thrombocytopenia
2026 · Kübra Oral, Zekeriya Aksöz, et al. · DAHUDER Medical Journal
PDF
Use of Daratumumab in Relapsed Refractory Multiple Myeloma and Clinical Experience
2026 · ORAL, KÜBRA · Acta Medica Young Doctors
A Case Report of Primer Refractory Diffuse Large B-cell Lymphoma
2025 · Zekeriya AKSÖZ, Ayşe UYSAL, et al. · Hematology Transfusion and Cell Therapy
Mi̇yeloproli̇ferati̇f Neoplazmlarda Splankni̇k Ven Trombozunun Değerlendi̇ri̇lmesi̇: Thd Kroni̇k Mi̇yelosi̇ter Lösemi̇ Ve Kroni̇k Mi̇yeloproli̇ferati̇f Neoplazmlar Ve Hemostaz - Tromboz Bi̇li̇msel Alt Komi̇teleri̇ Çok Merkez Çalişmasi
2025 · CÖMERT, MELDA, KARS, TAHA ULUTAN, et al. · Kocaeli Üniversitesi - AVESİS
Mi̇yeloproli̇ferati̇f Neoplazmlarda Splankni̇k Ven Trombozunun Değerlendi̇ri̇lmesi̇: Thd Kroni̇k Mi̇yelosi̇ter Lösemi̇ Ve Kroni̇k Mi̇yeloproli̇ferati̇f Neoplazmlar Ve Hemostaz - Tromboz Bi̇li̇msel Alt Komi̇teleri̇ Çok Merkez Çalişmasi
2025 · EŞKAZAN, AHMET EMRE, ÜMİT, ELİF GÜLSÜM, et al. · Bursa Uludag University - AVESIS
Single-center Experience in Relapsed/refractory Non-hodgkin’s Lymphoma (relaps/refrakter Non Hodgki̇n Lenfomalarda Tek Merkez Deneyi̇mi̇)
2022 · Hatice TERZİ, Kübra ORAL, et al. · Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi
PDF
Sklerodermalı Hastalarda Kan ve Tükürükte Sklerostin Düzeyleri
2019 · Önalan, Erhan, Oral, Kübra, et al. · DSpace - FIRAT (Fırat University)
Looking for the levels of urotensin-2 in blood and saliva of the newly diagnosed and metformin using diabetes mellitus patients
2019 · ORAL, KÜBRA · DSpace - FIRAT (Fırat University)
Works count: 19
Citation count: 21
H-index: 3
I10-index:
Year
Topic
Type